Dr. Weiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
Box 356115
Seattle, WA 98195Phone+1 206-598-7688Fax+1 206-568-7698
Summary
- Dr. Michael Weiss is a neurologist in Seattle, WA and is affiliated with University of Washington Medical Center. He received his medical degree from Albert Einstein College of Medicine and has been in practice 26 years. He specializes in neuromuscular medicine and is experienced in general neurology, swallowing disorders, neuromuscular medicine, and clinical neurophysiology.
Education & Training
National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 1996 - 2000
University of Maryland Medical Center Midtown CampusNeuromuscular Disease, 1995 - 1996
MedStar Health/Georgetown University HospitalResidency, Neurology, 1992 - 1995- MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 1991 - 1992
Albert Einstein College of MedicineClass of 1991
Certifications & Licensure
WA State Medical License 2001 - 2025
MD State Medical License 1995 - 2001- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Top Doctor Seattle Magazine, 2017-2023
- Top Doctors Castle Connolly, 2013-2023
- Top Doctor Seattle Metropolitan Magazine, 2012-2014, 2017
Clinical Trials
- Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) Start of enrollment: 2013 Jul 01
- Therapy in Amyotrophic Lateral Sclerosis (TAME) Start of enrollment: 2018 Nov 07
- Mexiletine in Sporadic Amyotrophic Lateral Sclerosis Start of enrollment: 2016 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Real world experience with sodium phenylbutyrate-taurursodiol for ALS: Lessons learned from a failed drug.Nicholas Olney, Michael D Weiss
Muscle & Nerve. 2024-09-01 - 2 citationsImprovement of fatigue in generalised myasthenia gravis with zilucoplan.Michael D Weiss, Miriam Freimer, M Isabel Leite, Angelina Maniaol, Kimiaki Utsugisawa
Journal of Neurology. 2024-05-01 - 2 citationsLong-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.James F Howard Jr, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge
Therapeutic Advances in Neurological Disorders. 2024-01-01
Press Mentions
ALS Update: Drug Therapy Continues to Offer Little BenefitOctober 21st, 2024
Everything You Know About Muscle Cramps Is WrongDecember 29th, 2018
New Clinical Pilot Studies Will Use Biomarkers to Speed Therapy DevelopmentFebruary 10th, 2016
Committees
- Member, NEALS Executive Committee 2017 - Present
- Chair, Exam Committee, ABEM 2014 - 2017
- Member, Exam Committee, ABEM 2014 - 2017
- Member, Limb Girdle Muscular Dystrophy Guidelines Committee, AAN 2013 - 2014
- Member, Marketing Committee, AANEM 2010 - 2012
Professional Memberships
- Member
- American Association of Neuromuscular Diseases and Electrodiagnostic MedicineMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
